Status:
RECRUITING
Advanced Diffusion Imaging in Renal Cancer Patients
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Renal Cancer
Eligibility:
All Genders
21-85 years
Phase:
NA
Brief Summary
The objective of this study is to apply advanced diffusion imaging in a two-pronged assessment of renal mass patients: (1) characterization of lesion malignancy and subtype, and (2) prediction of rena...
Eligibility Criteria
Inclusion
- Renal mass patients scheduled for laparoscopic partial nephrectomy.
- eGFR above 30 ml/min/m2.
- Ages 21 to 85
- Must be willing and able to provide consent.
Exclusion
- All metal implants and dental implants that have ferromagnetic properties and are unsafe at 3.0 T.
- Pregnant women are not eligible for participating in this study.
- Acute claustrophobia
Key Trial Info
Start Date :
December 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06116253
Start Date
December 1 2022
End Date
December 1 2028
Last Update
June 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016